Risks and benefits of postmenopausal combined hormone replacement therapy-Reference-Cited by-同舟云学术

Risks and benefits of postmenopausal combined hormone replacement therapy

Published:2002-08 Issue:4 Volume:177 Page:173-174
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Tattersall Martin H N¹²

Affiliation:

1. *Professor Tattersall is writing on behalf of the ADEC Expert Committee (L F Arnolda, B K Armstrong, R A Ayton, J J McNeil, M Michael, D J Topliss).

2. Department of Cancer Medicine, University of Sydney, NSW.

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.2002.tb04724.x

Reference5 articles.

1. Hormone replacement therapies in women at risk of cardiovascular disease and osteoporosis in South Australia in 1997

2. Long‐term hormone replacement therapy;MacLennan AH;Aust Prescriber,2000

3. Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?

4. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

5. Failure of Estrogen Plus Progestin Therapy for Prevention

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health Outcomes Associated with Hormone Therapy in Australian Women;Current Drug Safety;2009-09-01

2. Patients' and clinicians' attitudes after the Women's Health Initiative study;Menopause;2004-01

3. Current Awareness: Pharmacoepidemiology and Drug Safety;Pharmacoepidemiology and Drug Safety;2003